Edwards Lifesciences Reports Commencement Of US Pivotal Trial Evaluating Its Self-Expanding CENTERA Transcatheter Valve For Sever, Symptomatic Aortic Stenosis Patients At Intermediate Risk Of Open-Heart Surgery